A repurposed drug JAK blocker, used for rheumatoid arthritis, discovered to have potential for severe Covid via #AI, in a randomized trial, has a very significant reduction of mortality (more than dexamethasone or IL-6 blockade) and excellent safetyhttps://t.co/XcW53PtZTr pic.twitter.com/hMNL0ASnrl
— Eric Topol (@EricTopol) September 1, 2021